First PCSK9 Inhibitor Approved for Blanket Prevention of Heart Disease

1 brandonb 1 8/26/2025, 2:37:48 AM medpagetoday.com ↗

Comments (1)

brandonb · 5h ago
PCSK9 inhibitors are advanced drugs for heart disease that cost $5,850 per year. They use a different mechanism than statins.

While this FDA approval for primary prevention doesn't guarantee insurance coverage, it's one more step in that direction.